$7.25 Bn Antibody Fragments Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts to 2028
15 janv. 2024 08h58 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Antibody Therapeutic Market Research Report 2024-2033 Featuring Key Players - AbbVie, Amgen, Johnson & Johnson Services, Eli Lilly and Co, and Hoffmann-La Roche
05 janv. 2024 04h53 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and...
Cancer Biological Therapy Market Size Worth USD 211.23 Billion in 2032 | Emergen Research
03 janv. 2024 08h24 HE
|
Emergen Research
Vancouver, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global cancer biological therapy market reached USD 99.00 Billion in 2022, expected to grow at a rapid CAGR of 8.0% during the forecast period....
Biologics Market Report 2024-2034 - Advances in Regenerative Medicine and Cell Biology Driving Market Growth
28 déc. 2023 04h48 HE
|
Research and Markets
Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. Revenue for the Biologics Market is forecast to surpass...
Continuous Bioprocessing Market Forecast to Surge at 22.4% CAGR, Driven by Rising Biopharmaceutical Demand and Adoption by CDMOs/CMOs
22 déc. 2023 04h48 HE
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation...
Bispecific Antibody Competitive Landscape Report Unveils Comprehensive Insights on Therapeutics Assessment and Growth Dynamics in the Global Market
21 déc. 2023 09h48 HE
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Bispecific antibody - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. Amidst rapid advancements in the...
Global Continuous Bioprocessing Market 2024-2033: Comprehensive Analysis of Applications, Products, and Innovations
21 déc. 2023 04h38 HE
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Bioprocessing Market: Focus on Application, Product, Process, End Users, Region, and Competitive Landscape - Analysis and Forecast,...
Bioreactors Market Forecasts to 2033: Robust Growth, Demand for Single-use Technologies and Regional Insights
19 déc. 2023 04h48 HE
|
Research and Markets
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Bioreactors Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global bioreactors market is poised for...
Global Claudin 18.2 Targeted Therapy Research Report 2023-2028: Milestone Approval - Zolbetuximab's FDA Approval Paves the Way as the First CLDN18.2-Targeted Drug
15 déc. 2023 05h18 HE
|
Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
13 déc. 2023 14h03 HE
|
Spherix Global Insights
Exton, PA, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Several clinical trials are underway for Bruton’s tyrosine kinase inhibitors (BTKi) targeting relapsing and progressive multiple sclerosis (RMS/PPMS)....